---
schema_version: "secwatch.filing_event.v1"
accession: "0001613103-22-000058"
form_type: "8-K"
ticker: "MDT"
cik: "0001613103"
company_name: "Medtronic plc"
filed_at: "2022-11-22T23:59:59+00:00"
generated_at: "2026-06-21T14:10:32.005199+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Medtronic Q2 FY2023 revenue down 3%; lowers FY2023 EPS guidance to $5.25-$5.30

## Summary
- Revenue $7.585B, organic growth +2%; GAAP EPS $0.32 (down 67%), non-GAAP EPS $1.30 (down 2%).
- FY2023 non-GAAP EPS guidance cut to $5.25-$5.30; H2 organic revenue growth expected 3.5%-4.0%.
- Tax reserve adjustment of $764M from U.S. Tax Court opinion weighed on GAAP earnings.
- Segment organic growth: Cardiovascular +4%, Medical Surgical -3%, Neuroscience +5%, Diabetes +3%.
- CEO cites slower procedure/supply recovery; executing cost reductions and supply chain improvements.

## SEC filing metadata
- accession: 0001613103-22-000058
- form_type: 8-K
- ticker: MDT
- cik: 0001613103
- company_name: Medtronic plc
- filed_at: 2022-11-22T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000058/0001613103-22-000058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000058/mdt-20221122.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001613103-22-000058
- JSON: https://secwatch.observer/filing/0001613103-22-000058.json
- Plain text: https://secwatch.observer/filing/0001613103-22-000058.txt

## Key facts
- Earnings Releases
  Medtronic plc reported second quarter of fiscal year 2023, which ended October 28, 2022 results: revenue $7.585 billion, net income $427 million, EPS $0.32.
  - Period: second quarter of fiscal year 2023, which ended October 28, 2022
  - Revenue: $7.585 billion
  - Net income: $427 million
  - EPS: $0.32
  - Result: reported results
  source text: Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2023, which ended October 28, 2022. Key Highlights • Revenue of $7.6 billion decreased 3% as reported and increased 2% organic • GAAP diluted EPS of $0.32 decreased 67%; non-GAAP diluted EPS of $1.30 decreased 2% • Company updates guidance; expects organic revenue to accelerate in second half
  evidence_url: https://www.sec.gov/Archives/edgar/data/1613103/000161310322000058/0001613103-22-000058-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.